Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
Authors
Keywords
-
Journal
ENDOCRINE PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-18
DOI
10.1007/s12022-021-09662-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase 2 KEYNOTE-158 Study
- (2020) Jonathan R Strosberg et al. CLINICAL CANCER RESEARCH
- Pancreatic Neuroendocrine Neoplasms: Landscape and Horizon
- (2020) Laura H. Tang ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- c-MET Inhibition: Novel Treatment for Sporadic and MEN1-associated GEP NET
- (2020) Maya Elena Lee et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors
- (2020) Renuka V. Iyer et al. CANCER
- Gastric Neuroendocrine Tumors from Long‐Term Proton Pump Inhibitor Users are Indolent Tumors with Good Prognosis
- (2020) Vincent Quoc‐Huy Trinh et al. HISTOPATHOLOGY
- Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion
- (2020) Sandrine Petignot et al. HORMONE AND METABOLIC RESEARCH
- New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL‐cell tumours related to hypergastrinaemia
- (2020) Stefano La Rosa et al. HISTOPATHOLOGY
- Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets
- (2019) Ha Young Park et al. HUMAN PATHOLOGY
- Surufatinib in advanced well-differentiated neuroendocrine tumors: a multicenter, single-arm, open-label, phase Ib/II trial
- (2019) Jian Ming Xu et al. CLINICAL CANCER RESEARCH
- MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives
- (2019) Germano Gaudenzi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Final results of the TALENT trial (GETNE1509): a prospective multicohort phase II study of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs).
- (2019) Jaume Capdevila et al. JOURNAL OF CLINICAL ONCOLOGY
- The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours
- (2019) Aldo Scarpa ANNALES D ENDOCRINOLOGIE
- Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures
- (2019) Lorena Lechuga et al. Expert Review of Neurotherapeutics
- A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms
- (2019) Taymeyah Al-Toubah et al. NEUROENDOCRINOLOGY
- Treatment Options for Pancreatic Neuroendocrine Tumors
- (2019) Amit Akirov et al. Cancers
- Comprehensive characterization of a Canadian cohort of von Hippel‐Lindau disease patients
- (2019) Yasser Salama et al. CLINICAL GENETICS
- Non-conventional doses of somatostatin analogs in patients with progressing well differentiated neuroendocrine tumor
- (2019) Giuseppe Lamberti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms
- (2019) Edward Wolin et al. PLoS One
- Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm
- (2019) Federica Cavalcoli et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Management of Small Bowel Neuroendocrine Tumors
- (2019) Larouche et al. Cancers
- Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times
- (2018) Somak Roy et al. GASTROENTEROLOGY
- Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
- (2018) Sara Pusceddu et al. GASTROENTEROLOGY
- Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3
- (2018) Björn Konukiewitz et al. HUMAN PATHOLOGY
- Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma
- (2018) Kwun Wah Wen et al. HUMAN PATHOLOGY
- Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
- (2018) Andrea Mafficini et al. JOURNAL OF ENDOCRINOLOGY
- A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Anna Malczewska et al. NEUROENDOCRINOLOGY
- Endocrine pathology: past, present and future
- (2018) Sylvia L. Asa et al. PATHOLOGY
- MAFAmissense mutation causes familial insulinomatosis and diabetes mellitus
- (2018) Donato Iacovazzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review
- (2018) Yoichiro Okubo et al. Frontiers in Oncology
- 1308OActivity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
- (2018) J C Yao et al. ANNALS OF ONCOLOGY
- A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
- (2017) Jan P Dumanski et al. ENDOCRINE-RELATED CANCER
- The future: genetics advances in MEN1 therapeutic approaches and management strategies
- (2017) Sunita K Agarwal ENDOCRINE-RELATED CANCER
- Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
- (2017) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET).
- (2017) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
- (2017) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20%
- (2017) Björn Konukiewitz et al. MODERN PATHOLOGY
- HIF1A and EPAS1 potentiate hypoxia-induced upregulation of inhibin alpha chain expression in human term cytotrophoblasts in vitro
- (2017) C.L. Depoix et al. MOLECULAR HUMAN REPRODUCTION
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy
- (2017) Rocio Garcia-Carbonero et al. NEUROENDOCRINOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors
- (2017) Ramon Salazar et al. ONCOLOGIST
- Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors
- (2017) Cemal Yazici et al. WORLD JOURNAL OF GASTROENTEROLOGY
- DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
- (2017) Joo Kyung Park et al. Oncotarget
- Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis
- (2017) Elettra Merola et al. Oncotarget
- Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
- (2017) E T Aristizabal Prada et al. Endocrine Connections
- A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
- (2016) Laura H. Tang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study
- (2016) S. Faivre et al. ANNALS OF ONCOLOGY
- Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus
- (2016) Simron Singh et al. CANCER TREATMENT REVIEWS
- Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
- (2016) Joo Young Kim et al. CLINICAL CANCER RESEARCH
- Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
- (2016) Aatur D. Singhi et al. CLINICAL CANCER RESEARCH
- HIF2Again-of-function mutations detected in duodenal gangliocytic paraganglioma
- (2016) Zhengping Zhuang et al. ENDOCRINE-RELATED CANCER
- A phase II study of axitinib in advanced neuroendocrine tumors
- (2016) J R Strosberg et al. ENDOCRINE-RELATED CANCER
- Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
- (2016) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases
- (2016) Alessandro Vanoli et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
- (2016) G. Delle Fave et al. NEUROENDOCRINOLOGY
- The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
- (2016) Seung Tae Kim et al. Journal of Cancer
- Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases
- (2016) Zeynep Koşaloğlu et al. OncoImmunology
- A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
- (2016) Kjell Oberg et al. Endocrine Connections
- Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
- (2015) E. Grande et al. ANNALS OF ONCOLOGY
- Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
- (2015) A. Karpathakis et al. CLINICAL CANCER RESEARCH
- Cytomorphology of neuroendocrine tumours of the gallbladder
- (2015) R. Yadav et al. CYTOPATHOLOGY
- Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors
- (2015) A. Dasari et al. ENDOCRINE-RELATED CANCER
- Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour
- (2015) Oriol Calvete et al. HUMAN MOLECULAR GENETICS
- Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor
- (2015) Nobuyoshi Takizawa et al. HUMAN PATHOLOGY
- Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
- (2015) Jarosław B. Ćwikła et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon Cell Hyperplasia and Neoplasia With and Without Glucagon Receptor Mutations
- (2015) Bence Sipos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Telotristat Etiprate for Carcinoid Syndrome: A Single-Arm, Multicenter Trial
- (2015) Marianne Pavel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
- (2015) Timothy J. Hobday et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
- (2015) Alexandria T Phan et al. LANCET ONCOLOGY
- High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor
- (2015) Yoon Suk Lee et al. MEDICINE
- Epigenetic Regulation of the lncRNA MEG3 and Its Target c-MET in Pancreatic Neuroendocrine Tumors
- (2015) Sita D. Modali et al. MOLECULAR ENDOCRINOLOGY
- Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells
- (2015) Yvonne Arvidsson et al. NEUROENDOCRINOLOGY
- Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors
- (2015) James C. Yao et al. PANCREAS
- Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update
- (2015) Irene Esposito et al. PANCREATOLOGY
- DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors
- (2015) Alexandre How-Kit et al. Epigenomics
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy
- (2015) Kei Mitsuhashi et al. Oncotarget
- Genetics of pancreatic neuroendocrine tumors: implications for the clinic
- (2015) Antonio Pea et al. Expert Review of Gastroenterology & Hepatology
- Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
- (2015) Su-Chen Li et al. PLoS One
- Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma
- (2015) Laura Soucek et al. NEOPLASIA
- Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
- (2014) Alfredo Berruti et al. BMC CANCER
- Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations
- (2014) M Moschetta et al. BRITISH JOURNAL OF PHARMACOLOGY
- Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo
- (2014) T P Wyche et al. CANCER GENE THERAPY
- Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms
- (2014) Gregory Kaltsas et al. CLINICAL ENDOCRINOLOGY
- Neuroendocrine Pathology of the Stomach: The Parma Contribution
- (2014) Cesare Bordi ENDOCRINE PATHOLOGY
- Hyperplasia to Neoplasia Sequence of Duodenal and Pancreatic Neuroendocrine Diseases and Pseudohyperplasia of the PP-cells in the Pancreas
- (2014) Günter Klöppel et al. ENDOCRINE PATHOLOGY
- Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial
- (2014) Michel Ducreux et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial
- (2014) Emmanuel Mitry et al. EUROPEAN JOURNAL OF CANCER
- Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells
- (2014) Ji Tae Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Gastric neuroendocrine neoplasms and related precursor lesions
- (2014) Stefano La Rosa et al. JOURNAL OF CLINICAL PATHOLOGY
- Dynamic Epigenetic Regulation by Menin During Pancreatic Islet Tumor Formation
- (2014) Wenchu Lin et al. MOLECULAR CANCER RESEARCH
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
- (2013) H K Ahn et al. BRITISH JOURNAL OF CANCER
- Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
- (2013) Jennifer A. Chan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors
- (2013) Katarina Edfeldt et al. ENDOCRINE-RELATED CANCER
- Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)
- (2013) Daniel Castellano et al. EUROPEAN JOURNAL OF CANCER
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
- (2013) KATHRIN ZITZMANN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The genomic landscape of small intestine neuroendocrine tumors
- (2013) Michaela S. Banck et al. JOURNAL OF CLINICAL INVESTIGATION
- New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia
- (2013) Karel Pacak et al. JOURNAL OF CLINICAL ONCOLOGY
- Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
- (2013) Su-Chen Li et al. MODERN PATHOLOGY
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- (2013) Joshua M Francis et al. NATURE GENETICS
- Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors
- (2013) Catharina Larsson NEUROENDOCRINOLOGY
- Precursor lesions of endocrine system neoplasms
- (2013) Ozgur Mete et al. PATHOLOGY
- Gastrin: A Distinct Fate of Neurogenin3 Positive Progenitor Cells in the Embryonic Pancreas
- (2013) Yaron Suissa et al. PLoS One
- Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel–Lindau disease
- (2013) Hasan Gucer et al. VIRCHOWS ARCHIV
- Tenascin-C Downregulates Wnt Inhibitor Dickkopf-1, Promoting Tumorigenesis in a Neuroendocrine Tumor Model
- (2013) Falk Saupe et al. Cell Reports
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
- (2012) Shinichi Yachida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
- (2012) H. Sorbye et al. ANNALS OF ONCOLOGY
- A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
- (2012) Diane L. Reidy-Lagunes et al. CANCER
- The FGFR4-G388R Single-Nucleotide Polymorphism Alters Pancreatic Neuroendocrine Tumor Progression and Response to mTOR Inhibition Therapy
- (2012) S. Serra et al. CANCER RESEARCH
- Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients
- (2012) D. Speisky et al. CLINICAL CANCER RESEARCH
- Unusual DNA mismatch repair–deficient tumors in Lynch syndrome: a report of new cases and review of the literature
- (2012) Yevgeniy Karamurzin et al. HUMAN PATHOLOGY
- Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors
- (2012) Michael H�pfner INTERNATIONAL JOURNAL OF ONCOLOGY
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
- (2012) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
- (2012) Roeland F de Wilde et al. MODERN PATHOLOGY
- SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia
- (2012) Zhengping Zhuang et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
- (2012) G. M. Blumenthal et al. ONCOLOGIST
- von Hippel-Lindau disease–associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms
- (2012) Simon Turcotte et al. SURGERY
- Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review
- (2012) Akshat Saxena et al. SURGICAL ONCOLOGY-OXFORD
- Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex
- (2011) AM Larson et al. CLINICAL GENETICS
- Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype
- (2011) Donatella Malanga et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Preclinical and Clinical Study of Lithium in Low-Grade Neuroendocrine Tumors
- (2011) S. J. Lubner et al. ONCOLOGIST
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
- (2010) Robert T. Jensen et al. CANCER
- Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors
- (2010) Janet L. Cunningham et al. GENES CHROMOSOMES & CANCER
- Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2 - clinical implications
- (2010) Mehtap Cakir et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Insulinomatosis
- (2009) Martin Anlauf et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids
- (2009) Ellinor Andersson et al. ENDOCRINE-RELATED CANCER
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression
- (2009) Katharina Ruebel et al. MODERN PATHOLOGY
- Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell Tumor
- (2009) Cuiqi Zhou et al. PANCREAS
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Cystic Pancreatic Endocrine Neoplasms: A Distinct Tumor Type?
- (2008) Liliana Bordeianou et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Nesidioblastosis and Hyperplasia of ?? Cells, Microglucagonoma, and Nonfunctioning Islet Cell Tumor of the Pancreas
- (2008) Run Yu et al. PANCREAS
- Is Serous Cystadenoma of the Pancreas a Model of Clear-Cell-Associated Angiogenesis and Tumorigenesis?
- (2008) Duangpen Thirabanjasak et al. PANCREATOLOGY
- Carcinoid tumor of the common bile duct: A rare complication of von Hippel-Lindau syndrome
- (2008) Otmane Nafi di et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started